226 related articles for article (PubMed ID: 38339282)
1. Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer.
Ray I; Möller-Levet CS; Michael A; Butler-Manuel S; Chatterjee J; Tailor A; Ellis PE; Meira LB
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339282
[TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and their relationship to endometrial cancer risk: A systematic review and meta-analysis.
Ellis PE; Barron GA; Bermano G
Gynecol Oncol; 2020 Aug; 158(2):507-516. PubMed ID: 32507648
[TBL] [Abstract][Full Text] [Related]
3. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.
Ayabe T; Tsutsumi O; Sakai H; Yoshikawa H; Yano T; Kurimoto F; Taketani Y
Endocr J; 1997 Jun; 44(3):419-24. PubMed ID: 9279518
[TBL] [Abstract][Full Text] [Related]
5. Association of adipocytokines (leptin, adiponectin TNF-alpha), insulin and proinsulin with diabetes--the Mumbai Obesity Project [MOP].
Lele RD; Joshi SR; Gupte A
J Assoc Physicians India; 2006 Sep; 54():689-96. PubMed ID: 17212015
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
7. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands.
de Nooijer AH; Kooistra EJ; Grondman I; Janssen NAF; Joosten LAB; van de Veerdonk FL; Kox M; Pickkers P; Netea MG;
Clin Obes; 2023 Apr; 13(2):e12568. PubMed ID: 36426776
[TBL] [Abstract][Full Text] [Related]
8. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
9. Adipocytokines and disease progression in endometrial cancer: a systematic review.
Ray I; Meira LB; Michael A; Ellis PE
Cancer Metastasis Rev; 2022 Mar; 41(1):211-242. PubMed ID: 34951691
[TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
[TBL] [Abstract][Full Text] [Related]
11. Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease.
Anandaraj AA; Syed Ismail PM; Namis SM; Bajnaid YJ; Shetty SB; Almutairi KM
Curr Diabetes Rev; 2017; 13(3):330-335. PubMed ID: 27296168
[TBL] [Abstract][Full Text] [Related]
12. Obesity, adipocytokines, and insulin resistance in breast cancer.
Rose DP; Komninou D; Stephenson GD
Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
[TBL] [Abstract][Full Text] [Related]
13. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of markers of insulin resistance and endometrial cancer risk.
Friedenreich CM; Langley AR; Speidel TP; Lau DC; Courneya KS; Csizmadi I; Magliocco AM; Yasui Y; Cook LS
Endocr Relat Cancer; 2012 Dec; 19(6):785-92. PubMed ID: 23033315
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
16. Altered gene expression of VEGF, IGFs and H19 lncRNA and epigenetic profile of H19-DMR region in endometrial tissues of women with endometriosis.
Kamrani S; Amirchaghmaghi E; Ghaffari F; Shahhoseini M; Ghaedi K
Reprod Health; 2022 Apr; 19(1):100. PubMed ID: 35459174
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
[TBL] [Abstract][Full Text] [Related]
18. Markers of obesity and growth in preeclamptic and normotensive pregnant women.
Kharb S; Bala J; Nanda S
J Obstet Gynaecol; 2017 Jul; 37(5):610-615. PubMed ID: 28467127
[TBL] [Abstract][Full Text] [Related]
19. The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer.
Stępień S; Olczyk P; Gola J; Komosińska-Vassev K; Mielczarek-Palacz A
Cells; 2023 Apr; 12(8):. PubMed ID: 37190027
[TBL] [Abstract][Full Text] [Related]
20. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
